✦ LIBER ✦

Regional variation in the prescription of lipid lowering therapy in patients with coronary artery disease

✍ Scribed by C.A. Sueta; M. Chowdhury; D. Biggs; S. Boccuzzi; S.C. Smith Jr.; R.J. Simpson Jr

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The impact of lipid-lowering therapy usi

✍ K.S. Woo; L.L.T. Chan; P. Chook; A.S.P. Cheung; R.C.W. Chiu; K. Tang; W.W.M. Cha 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 164 KB

LIPID LOWERING EFFICACY OF ROSUVASTATIN

✍ Ostergren, J.; Malmstrom, R.; Jorgensen, L.; Walldius, G. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 87 KB

Factors Associated With Discharge Lipid-

✍ Nancy M. Albert; Kimberly K. Birtcher; Christopher P. Cannon; David C. Goff Jr.; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Intensive Lipid Lowering With Atorvastat

✍ Shepherd, James; Kastelein, John J.P.; Bittner, Vera A.; Carmena, Rafael; Deedwa 📂 Article 📅 2008 🏛 Mayo Clinic 🌐 English ⚖ 219 KB

Lipid lowering in patients with coronary

✍ Jean Davignon 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 245 KB

HDL Particle Number in Patients with Ang

✍ Malave, Hector; Castro, Manuel; Seigle, Nance E.; Nelson, Susan; Winegar, Debora 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 182 KB